中文 | English
Return
Total: 1090 , 1/109
Show Home Prev Next End page: GO
Author:(Nanfang LI)

2.Antihypertensive therapy in cerebrovascular disease patients with hypertension

Nanfang LI

Chinese Journal of Practical Internal Medicine 2003;0(01):-

3.Genetic aspects in primary aldosteronism

Hongjian LI ; Nanfang LI

Chinese Journal of Endocrinology and Metabolism 2013;29(12):1070-1072

4.The Study on Content of Myosin Light Chain Phosphatase of SHR' Different Organs.

Nanfang LI ; Junli HU

Journal of Medical Research 2006;0(09):-

5.Discussion on several points of treating hemodynamic cerebral infarction by Buyang-huanwu decoction

Li YANG ; Nanfang CHENG ; Juan JIAO

International Journal of Traditional Chinese Medicine 2010;32(3):275-276

6.Influence of Cushing′s syndrome on metabolic indexes

Jianqiong KONG ; Junguo LONG ; Nanfang LI

Chinese Journal of cardiovascular Rehabilitation Medicine 2014;23(2):175-178

7.Expression of vascular endothelial growth factor in deep second-degree scald wounds in rats.

Qi WU ; Jia-Han WANG ; Zhi-Qing LI ; Jia-Liang REN ; Yong-Heng WU

Acta Academiae Medicinae Sinicae 2014;36(6):650-653

8.A clinical comparative study on Traditional Chinese Medicine serving as consolidation treatment in patients with advanced non-small cell lung cancer.

Jinhan LI

Chinese Journal of Lung Cancer 2007;10(6):520-522

9.Evaluation of awareness of hypertension prevention and treatment knowledge before and after intensive training in physicians from hospitals at different levels in Xinjiang

Nanfang LI ; Jing HONG ; Junli HU ; Hongmei WANG ; Sha TAO

Chinese Journal of General Practitioners 2010;9(6):394-396

10.Application of SUSPPUP ratio in patients with primary aldosteronism

Jianqiong KONG ; Nanfang LI ; Feiya ZU ; Delian ZHANG ; Guijuan CHANG

Chinese Journal of Endocrinology and Metabolism 2014;30(7):587-591

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 1090 , 1/109 Show Home Prev Next End page: GO